Benji Benjamin
 
Dr Benjamin was previously clinical director of radiation oncology at Auckland City Hospital where he was a specialist for 26 years. He was named an Officer New Zealand Order of Merit in the 2008 New Year's Honours list for his services to medicine and the community.

Dr Benjamin is a Fellow of the Royal Australian and NZ College of Radiologists and Dean of the Oceania University of Medicine.

He has worked with N.Z.A.I.D and Ministry of Foreign Affairs for 10 years (1996-2005) as the coordinator of New Zealand Medical Treatment Scheme for seven South Pacific countries (Fiji, Samoa, Tuvalu, Kiribati, Tonga, Solomon Islands and Vanuatu).

Dr CS Benjamin has over 140 publications and presentations in the medical journals and international conferences.

Dr Benjamin has participated in many clinical trials involving breast cancer, head and neck cancer and prostate cancer.

Dr Benjamin was the chairman of Auckland Breast Cancer Study group for several years. He was the examiner of Royal Australian College of Radiologists for 7 years. He was the member of the Educational Board of Australian and NZ College of Radiologists for 6 years.

His areas of interest include head and neck cancer, breast cancer, prostate cancer and palliative radiation treatment. "

 

 

Breast Cancer Symposium - Accelerated Partial Breast Irradiation
Pre-conference Workshop (Repeated) 
Thursday, 12 June 2014 Start 2:00pm Duration: 120mins Room 1
Start 4:30pm Duration: 120mins Room 1
Accelerated Partial Breast Irradiation (APBI)

Partial mastectomy is a well-established treatment modality for early breast cancer.

Three to five weeks of irradiation is given to the whole breast after partial mastectomy.

APBI treats only the lumpectomy bed with 1-2cm margins. High dose of radiation is given at shorter time.

Various approaches have been developed including conformal external beam radiation treatment and intra operative radiation therapy.

It is evident that APBI will play a role in the management of selected group of early breast cancer in the future.

However long term benefits and side effects are yet to be clearly identified.